- Home
- EVMN vs NKX Comparison
EVMN vs NKX Comparison
Compare EVMN & NKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVMN | NKX |
|---|---|---|
| Founded | 2020 | 2002 |
| Country | United States | United States |
| Employees | 48 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 717.5M | 647.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EVMN | NKX |
|---|---|---|
| Price | $20.42 | $12.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $43.88 | N/A |
| AVG Volume (30 Days) | ★ 359.1K | 125.5K |
| Earning Date | 06-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.37% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.89 | $11.45 |
| 52 Week High | $33.20 | $13.20 |
Technical Indicators
Market Signals| Indicator | EVMN | NKX |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 56.39 |
| Support Level | $16.16 | $12.40 |
| Resistance Level | $21.21 | $12.69 |
| Average True Range (ATR) | 1.43 | 0.13 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 28.43 | 33.67 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About NKX Nuveen California AMT-Free Quality Municipal Income Fund
Nuveen California AMT-Free Quality Municipal Income Fund is a closed-end fixed income mutual fund. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. It invests across sectors such as healthcare, utilities, transportation, and housing.